Accordingly, after imprinting gut tropism in CD4+ T-cells, they were treated with the experimental peptides (TM6C, TM7C, or vehicle) and then i.v. transferred into Drd5−/− recipient mice undergoing DSS-induced colitis. Here, DRD5 is linked to colitis.